{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:38:17Z","timestamp":1791041897277,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03371-1","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T11:03:09Z","timestamp":1682679789000},"page":"223-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term outcome of treatments for Graves disease in the children and adolescent population"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5353-3316","authenticated-orcid":false,"given":"Mohammad","family":"Jawwad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Arsalan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Muhammad Mehdi","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ashad Ahmed","family":"Fatmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hasan","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozab","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shuraim","family":"Chola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"issue":"12","key":"3371_CR1","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nrendo.2013.193","volume":"9","author":"L Bartalena","year":"2013","unstructured":"L. Bartalena, Diagnosis and management of Graves disease: a global overview. Nat. Rev. Endocrinol. 9(12), 724\u2013734 (2013)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"16","key":"3371_CR2","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"T.J. Smith, L. Heged\u00fcs, Graves\u2019 disease. N. Engl. J. Med. 375(16), 1552\u20131565 (2016)","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"3371_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ando.2018.08.001","volume":"79","author":"J L\u00e9ger","year":"2018","unstructured":"J. L\u00e9ger, I. Oliver, D. Rodrigue, A.S. Lambert, R. Coutant, Graves\u2019 disease in children. Ann. Endocrinol. 79(6), 647\u2013655 (2018)","journal-title":"Ann. Endocrinol."},{"issue":"2","key":"3371_CR4","first-page":"207","volume":"26","author":"W Yu","year":"2020","unstructured":"W. Yu, N. Wu, L. Li, J. Wang, H. OuYang, H. Shen, Side effects of ptu and mmi in the treatment of hyperthyroidism: a systematic review and meta-analysis. Endocr. Pr. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol. 26(2), 207\u2013217 (2020)","journal-title":"Endocr. Pr. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"issue":"3","key":"3371_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000342920","volume":"1","author":"PN Taylor","year":"2012","unstructured":"P.N. Taylor, B. Vaidya, Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy. Eur. Thyroid J. 1(3), 176\u2013185 (2012). https:\/\/doi.org\/10.1159\/000342920","journal-title":"Eur. Thyroid J."},{"key":"3371_CR6","unstructured":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. The EQUATOR Network. https:\/\/www.equator-network.org\/reporting-guidelines\/prisma\/"},{"key":"3371_CR7","unstructured":"Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Res Methodol. 2022. https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/1471-2288-5-13"},{"issue":"6","key":"3371_CR8","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1210\/jcem-64-6-1241","volume":"64","author":"BM Lippe","year":"1987","unstructured":"B.M. Lippe, E.M. Landaw, S.A. Kaplan, Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J. Clin. Endocrinol. Metab. 64(6), 1241\u20131245 (1987)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3371_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1089\/thy.2012.0612","volume":"24","author":"H Ohye","year":"2014","unstructured":"H. Ohye, A. Minagawa, J.Y. Noh, K. Mukasa, Y. Kunii, N. Watanabe et al. Antithyroid drug treatment for graves\u2019 disease in children: a long-term retrospective study at a single institution. Thyroid J. Am. Thyroid Assoc. 24(2), 200\u2013207 (2014)","journal-title":"Thyroid J. Am. Thyroid Assoc."},{"issue":"5","key":"3371_CR10","doi-asserted-by":"publisher","first-page":"e20183034","DOI":"10.1542\/peds.2018-3034","volume":"143","author":"F Azizi","year":"2019","unstructured":"F. Azizi, M. Takyar, E. Madreseh, A. Amouzegar, Long-term methimazole therapy in juvenile Graves\u2019 disease: a randomized trial. Pediatrics 143(5), e20183034 (2019)","journal-title":"Pediatrics"},{"issue":"7","key":"3371_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4158\/EP-2019-0468","volume":"26","author":"T Mizokami","year":"2020","unstructured":"T. Mizokami, K. Hamada, T. Maruta, K. Higashi, J. Tajiri, Long-term outcomes of radioiodine therapy for Juvenile Graves disease with emphasis on subsequently detected thyroid nodules: a single institution experience from Japan. Endocr Pract 26(7), 729\u2013737 (2020)","journal-title":"Endocr Pract"},{"issue":"11","key":"3371_CR12","first-page":"1583","volume":"94","author":"R Barrio","year":"2005","unstructured":"R. Barrio, M. L\u00f3pez-Capap\u00e9, I. Martinez-Bad\u00e1s, A. Carrillo, J.C. Moreno, M. Alonso, Graves\u2019 disease in children and adolescents: response to long-term treatment. Acta Paediatr. Oslo Nor. 1992 94(11), 1583\u20131589 (2005)","journal-title":"Acta Paediatr. Oslo Nor. 1992"},{"issue":"5\u20136","key":"3371_CR13","first-page":"257","volume":"24","author":"H Sato","year":"2011","unstructured":"H. Sato, M. Minagawa, N. Sasaki, S. Sugihara, I. Kazukawa, K. Minamitani et al. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves\u2019 disease: efficacy and adverse reactions during initial treatment and long-term outcome. J. Pediatr. Endocrinol. Metab. JPEM 24(5\u20136), 257\u2013263 (2011)","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"issue":"6","key":"3371_CR14","first-page":"310","volume":"71","author":"F Kaguelidou","year":"2009","unstructured":"F. Kaguelidou, J.C. Carel, J. L\u00e9ger, Graves\u2019 disease in childhood: advances in management with antithyroid drug therapy. Horm. Res 71(6), 310\u2013317 (2009)","journal-title":"Horm. Res"},{"issue":"5","key":"3371_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/BF03346315","volume":"30","author":"AT Bossowski","year":"2007","unstructured":"A.T. Bossowski, V. Reddy, L.A. Perry, L.B. Johnston, K. Banerjee, J.C. Blair et al. Clinical and endocrine features and long-term outcome of Graves\u2019 disease in early childhood. J. Endocrinol. Invest 30(5), 388\u2013392 (2007)","journal-title":"J. Endocrinol. Invest"},{"issue":"4","key":"3371_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1515\/jpem-2018-0495","volume":"32","author":"E Bayramo\u011flu","year":"2019","unstructured":"E. Bayramo\u011flu, S. Elmaogullar\u0131, E. Sagsak, Z. Aycan, Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves\u2019 disease: a single-center experience. J. Pediatr. Endocrinol. Metab. JPEM 32(4), 341\u2013346 (2019)","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"issue":"6","key":"3371_CR17","first-page":"258","volume":"49","author":"TD Cheetham","year":"1998","unstructured":"T.D. Cheetham, P. Wraight, I.A. Hughes, N.D. Barnes, Radioiodine treatment of Graves\u2019 disease in young people. Horm. Res 49(6), 258\u2013262 (1998)","journal-title":"Horm. Res"},{"issue":"1","key":"3371_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1530\/EC-12-0049","volume":"2","author":"AN Cury","year":"2012","unstructured":"A.N. Cury, V.T. Meira, O. Monte, M. Marone, N.M. Scalissi, C. Kochi et al. Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves\u2019 disease. Endocr. Connect 2(1), 32\u201337 (2012)","journal-title":"Endocr. Connect"},{"issue":"3","key":"3371_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.pedneo.2019.12.009","volume":"61","author":"YT Chiang","year":"2020","unstructured":"Y.T. Chiang, W.H. Ting, C.Y. Huang, S.K. Huang, C.I. Chan, B.W. Cheng et al. Long-term outcomes of graves disease in children treated with anti-thyroid drugs. Pediatr. Neonatol. 61(3), 311\u2013317 (2020)","journal-title":"Pediatr. Neonatol."},{"issue":"1","key":"3371_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1687-9856-2011-14","volume":"2011","author":"N Nakatake","year":"2011","unstructured":"N. Nakatake, S. Fukata, J. Tajiri, Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves\u2019 disease. Int J. Pediatr. Endocrinol. 2011(1), 14 (2011)","journal-title":"Int J. Pediatr. Endocrinol."},{"issue":"4","key":"3371_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/cen.13099","volume":"85","author":"S Rabon","year":"2016","unstructured":"S. Rabon, A.M. Burton, P.C. White, Graves\u2019 disease in children: long-term outcomes of medical therapy. Clin. Endocrinol. 85(4), 632\u2013635 (2016)","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"3371_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.endinu.2017.11.014","volume":"65","author":"O Marques","year":"2018","unstructured":"O. Marques, A. Antunes, M.J. Oliveira, Treatment of Graves\u2019 disease in children: the Portuguese experience. Endocrinol. Diabetes Nutr. 65(3), 143\u2013149 (2018)","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"3371_CR23","unstructured":"Ottawa Hospital Research Institute. 2022. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"4","key":"3371_CR24","first-page":"623","volume":"72","author":"JR Reid","year":"2005","unstructured":"J.R. Reid, S.F. Wheeler, Hyperthyroidism: diagnosis and treatment. Am. Fam. Physician 72(4), 623\u2013630 (2005)","journal-title":"Am. Fam. Physician"},{"issue":"10047","key":"3371_CR25","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","volume":"388","author":"S De Leo","year":"2016","unstructured":"S. De Leo, S.Y. Lee, L.E. Braverman, Hyperthyroidism. Lancet Lond. Engl. 388(10047), 906\u2013918 (2016)","journal-title":"Lancet Lond. Engl."},{"issue":"9","key":"3371_CR26","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1210\/jc.2013-1954","volume":"98","author":"V Sundaresh","year":"2013","unstructured":"V. Sundaresh, J.P. Brito, Z. Wang, L.J. Prokop, M.N. Stan, M.H. Murad et al. Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta-analysis. J. Clin. Endocrinol. Metab. 98(9), 3671\u20133677 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3371_CR27","doi-asserted-by":"publisher","first-page":"e210073","DOI":"10.1530\/ETJ-21-0073","volume":"11","author":"CF Mooij","year":"2022","unstructured":"C.F. Mooij, T.D. Cheetham, F.A. Verburg, A. Eckstein, S.H. Pearce, J. L\u00e9ger et al. 2022 European Thyroid Association Guideline for the management of pediatric Graves\u2019 disease. Eur. Thyroid J. 11(1), e210073 (2022)","journal-title":"Eur. Thyroid J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03371-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03371-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03371-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T12:14:24Z","timestamp":1687781664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03371-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["3371"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03371-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"19 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}